Survival and treatment in older patients with ewing sarcoma: an analysis of the national cancer database

ConclusionAn age over 40 is associated with decreased survival for patients with EWS. Due to the rarity of EWS in this cohort, the optimal role of systemic treatment remains unknown and has yet to be clearly elucidated. Consequently, our findings suggest that older patients receive disparities in treatment which may be contributing to decreased survival rates.
Source: European Journal of Medical Research - Category: Research Source Type: research